BD Biosciences is a life sciences leader with more than 50 years of expertise in cell biology products and services. The Advanced Bioprocessing strategic platform developed products currently being used as critical components in the production of some of the most widely used drugs and vaccines on the global market today. BD Biosciences - Advanced Bioprocessing (BDB-AB) is playing a major role in biopharmaceutical drug production, enabling customers large and small to have a tremendous impact on the future of human healthcare. BDB-AB‘s novel portfolio of hydrolysates, cell culture media supplements and services is the optimal choice for your mammalian cell culture and bacterial fermentation bioprocessing needs.

For more information visit www.bdbiosciences.com/advbio

FrieslandCampina Domo has over 30 years of technical expertise in the manufacturing of protein hydrolysates. Consistent growth performance and reliable supply are important for diagnostic and biopharmaceutical customers. FrieslandCampina Domo understands this like no other. Our experience in hydrolysates manufacturing, flexibility and high-quality make us a valuable partner in cell nutrition.

DSM Biologics in partnership with Crucell N.V., offers the PER.C6® human cell line production platform for recombinant proteins and monoclonal antibodies. The combination of the PER.C6® platform, DSM’s manufacturing and Crucell’s clone generation services provide companies with a turn-key biologic manufacturing solution reducing cost, risk and time to market.

GE Healthcare Life Sciences provides a broad range of products and services for biomolecule separations at all scales. Chief products include: • ÄKTAdesign™ chromatography systems and BioProcess™ media • Filtration systems and devices • Wave Bioreactor™ and mixers • Cell separation for isolating and purifying cells, viruses, and sub-cellular particles • Fast Trak™ BioPharma Services. Our products are used in the manufacture of the majority of all FDA-approved biopharmaceuticals on the market. GE Healthcare Life Sciences is a part of GE Healthcare, a General Electric company with more than 42,000 employees, providing transformational medical technologies that are shaping a new age of patient care.

M-Scan is a world leader in contract analytical services and training based on mass spectrometry, chromatography and other protein and carbohydrate analytical techniques. We have 30 years experience in performing physicochemical characterisation of biotech products for research and regulatory submissions from four GLP/GMP accredited laboratories in the UK, USA, Switzerland and Germany.

Novasep develops, markets and operates innovative technologies to produce active molecules for the life sciences industry. Our research and development teams constantly innovate to design the next generation of processing in order to improve product quality and safety with lower production costs.

The applications of Novasep’s offering cover the pharmaceutical, biopharmaceutical, food, functional ingredient and bio-industries markets.

Our global solution for biopharmaceutical manufacturing includes:

• Bioprocess development: upstream and downstream processing; formulation; fill and finish,
• Out-sourcing solutions: contract biomanufacturing services, from early development to the clinical or commercial phase,
• In-sourcing solutions: chromatography and tangential flow filtration equipment, systems and consumables, from lab to industrial scale.

With Novasep, you will benefit from our process intelligence:

• coming from the cross-fertilization of our experience acquired within diverse applications,
• backed by our expertise in both using and developing our own technologies.